IPRATRIN ADULT UNI-DOSE ipratropium bromide 500 microgram/1mL (as monohydrate) inhalation ampoule
국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
환자 정보 전단 유효 성분:
ipratropium bromide monohydrate
제공처:
Alphapharm Pty Ltd
승인 상태:
Registered
환자 정보 전단
IPRATRIN UNI-DOSE
IPRATRIN UNI-DOSE ADULT
1
IPRATRIN
® UNI-DOSE
IPRATRIN
® ADULT UNI-DOSE
_contains the active ingredient ipratropium bromide _
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Ipratrin uni-dose and
Ipratrin Adult uni-dose.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have benefits and
risks. Your doctor has weighed the
risks of you using Ipratrin against the
benefits they expect it will have for
you.
IF YOU HAVE ANY CONCERNS ABOUT
USING THIS MEDICINE, TALK TO YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH YOUR
MEDICINE.
You may need to read it again.
WHAT IPRATRIN IS USED
FOR
Ipratrin is used to treat:
asthma
chronic obstructive bronchitis
people who have difficulty
breathing during or after surgery
using assisted ventilation
Asthma is a disease where the lining
of the lungs becomes inflamed (red
and swollen), making it difficult to
breathe. This may be due to an
allergy to house dust mites, smoke or
other irritants.
Chronic obstructive bronchitis is a
lung condition that can cause
difficulty in breathing, wheeziness
and constant coughing.
Ipratrin contains the active ingredient
ipratropium bromide. It belongs to a
group of medicines called
anticholinergic bronchodilators.
Ipratrin opens up the air passages in
people suffering from asthma,
chronic bronchitis and difficulty
breathing during or after surgery.
It begins to act quickly after use but
may take up to 2 hours to give
maximum benefit.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY IPRATRIN HAS
BEEN PRESCRIBED FOR YOU.
Your doctor may have prescribed it
for another reason.
Ipratrin is available only with a
doctor's prescription.
There is no evidence that Ipratrin is
addictive.
BEFORE YOU USE
IPRATRIN
_WHEN YOU MUST NOT USE IT _
DO NOT USE IPRATRIN IF YOU HAVE AN
ALLERGY TO:
ipratropium bromide or any other
medicines used to treat breathing
problems
similar medicines whic
전체 문서 읽기
제품 특성 요약
AUSTRALIAN PRODUCT INFORMATION
IPRATRIN UNI-DOSE
_(Ipratropium bromide monohydrate) Inhalation _
1
NAME OF THE MEDICINE
Ipratropium bromide monohydrate
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Ipratrin uni-dose 250
g/1 mL: contains 261
g ipratropium bromide monohydrate [equivalent to 250
g
ipratropium bromide (anhydrous)].
Ipratrin Adult uni-dose 500
g/1 mL: contains 522
g ipratropium bromide monohydrate [equivalent to
500
g ipratropium bromide (anhydrous)].
Ipratrin uni-dose 500
g/2 mL: contains 522
g ipratropium bromide monohydrate [equivalent to 500
g
ipratropium bromide (anhydrous)].
For the full list of excipients, see
SECTION 6.1 LIST OF EXCIPIENTS.
3
PHARMACEUTICAL FORM
Both strengths of Ipratrin Inhalation Solution come in plastic single
use ampoules containing a clear
colourless or almost colourless preservative free solution free from
suspended particles.
_ _
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Moderate asthmatic attacks; chronic forms of asthma; asthma in
patients with diminished cardiac reserve;
chronic obstructive bronchitis with bronchospasm; bronchospasm during
or after surgery, use during
assisted ventilation with a respirator.
Administration of Ipratrin via a nebuliser is intended for those
patients who cannot use a metered dose
aerosol.
4.2
DOSE AND METHOD OF ADMINISTRATION
DOSAGE (DOSE AND INTERVAL)
Dosage is dependent on the mode of inhalation and the quality of
nebulisation. The duration of inhalation
can be controlled by the dilution volume. It is advisable not to
greatly exceed the recommended daily dose
as this suggests additional therapeutic modalities may be needed.
Note:
The dosage should be adapted to the individual requirements of the
patient; patients should also be kept
under medical supervision during treatment. Unless otherwise
prescribed, the following doses are
recommended:
ADULTS
The recommended dose is 261 to 522
g [equivalent to 250 to 500
g ipratropium bromide (anhydrous)],
4 times daily, diluted to 2 to 3 mL with
전체 문서 읽기
